Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnab Das

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
BMC Ophthalmology|January 24, 2025
Innovator ranibizumab ComparEd to Biosimilar ranibizumab in combination with Expansile gas in submaculaR HemorrhaGe: the ICEBERG studyDebdulal Chakraborty, Tushar Kanti Sinha, Soumen Mondal, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 30, 2025
Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational StudyDebdulal Chakraborty, Sudipta Das, Aniruddha Maiti, et al.
The Journal of Biological Chemistry|December 11, 2025
Incorporation of arabinose-CTP and arabinose-UTP inhibits viral polymerases by inducing long pausesZiyang Xiao, Arnab Das, Abha Jain, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Real-World Comparison of Biosimilar Ranibizumab (Ranieyes) and Innovator Ranibizumab (Lucentis/Accentrix) Across Multiple Retinal Vascular Diseases (The BRIO Study)Debdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, et al.
International Immunopharmacology|June 11, 2013
Neem leaf glycoprotein is superior than cisplatin and sunitinib malate in restricting melanoma growth by normalization of tumor microenvironmentSubhasis Barik, Avishek Bhuniya, Saptak Banerjee, et al.
Indian Journal of Ophthalmology|May 19, 2023
Incidence, clinical features, risk factors, and outcomes of Intraocular inflammation following Brolucizumab in Indian eyes - A multicentric studyDebdulal Chakraborty, Soumen Mondal, Sabyasachi Sengupta, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 2, 2025
CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS StudyDebdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, et al.
Frontiers in Oncology|March 27, 2020
NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8<sup>+</sup> T CellsAvishek Bhuniya, Ipsita Guha, Nilanjan Ganguly, et al.
Iscience|December 8, 2021
Inhibition of extracellular vesicle-associated MMP2 abrogates intercellular hepatic miR-122 transfer to liver macrophages and curtails inflammationArnab Das, Sudarshana Basu, Diptankar Bandyopadhyay, et al.
Journal of Cardiovascular Development and Disease|December 22, 2022
Barth Syndrome: Psychosocial Impact and Quality of Life AssessmentAnandbir Bath, Oguz Akbilgic, David Wilbanks, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
BMC Ophthalmology|January 24, 2025
Innovator ranibizumab ComparEd to Biosimilar ranibizumab in combination with Expansile gas in submaculaR HemorrhaGe: the ICEBERG studyDebdulal Chakraborty, Tushar Kanti Sinha, Soumen Mondal, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 30, 2025
Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational StudyDebdulal Chakraborty, Sudipta Das, Aniruddha Maiti, et al.
The Journal of Biological Chemistry|December 11, 2025
Incorporation of arabinose-CTP and arabinose-UTP inhibits viral polymerases by inducing long pausesZiyang Xiao, Arnab Das, Abha Jain, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Real-World Comparison of Biosimilar Ranibizumab (Ranieyes) and Innovator Ranibizumab (Lucentis/Accentrix) Across Multiple Retinal Vascular Diseases (The BRIO Study)Debdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, et al.
International Immunopharmacology|June 11, 2013
Neem leaf glycoprotein is superior than cisplatin and sunitinib malate in restricting melanoma growth by normalization of tumor microenvironmentSubhasis Barik, Avishek Bhuniya, Saptak Banerjee, et al.
Indian Journal of Ophthalmology|May 19, 2023
Incidence, clinical features, risk factors, and outcomes of Intraocular inflammation following Brolucizumab in Indian eyes - A multicentric studyDebdulal Chakraborty, Soumen Mondal, Sabyasachi Sengupta, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 2, 2025
CompaRative Safety Analysis of Innovator and BioSimilar Ranibizumab in Chorioretinal Vascular Diseases - The CRsIBS StudyDebdulal Chakraborty, Tushar Kanti Sinha, Sourav Sinha, et al.
Frontiers in Oncology|March 27, 2020
NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8<sup>+</sup> T CellsAvishek Bhuniya, Ipsita Guha, Nilanjan Ganguly, et al.
Iscience|December 8, 2021
Inhibition of extracellular vesicle-associated MMP2 abrogates intercellular hepatic miR-122 transfer to liver macrophages and curtails inflammationArnab Das, Sudarshana Basu, Diptankar Bandyopadhyay, et al.
Journal of Cardiovascular Development and Disease|December 22, 2022
Barth Syndrome: Psychosocial Impact and Quality of Life AssessmentAnandbir Bath, Oguz Akbilgic, David Wilbanks, et al.
Pageof 8